Induction chemotherapy plus bevacizumab with versus without pemetrexed maintenance in patients with advanced NSCLC

Trial Profile

Induction chemotherapy plus bevacizumab with versus without pemetrexed maintenance in patients with advanced NSCLC

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Nov 2015

At a glance

  • Drugs Pemetrexed (Primary) ; Bevacizumab; Carboplatin; Vinorelbine
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Nov 2015 New trial record
    • 01 Nov 2015 Results published in the Anticancer Research
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top